JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 84 filers reported holding JOUNCE THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $243,000 | -35.0% | 35,700 | -1.9% | 0.00% | -25.0% |
| Q1 2021 | $374,000 | +175.0% | 36,400 | +87.6% | 0.00% | +100.0% |
| Q4 2020 | $136,000 | -14.5% | 19,400 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $159,000 | -77.2% | 19,400 | -80.8% | 0.00% | -80.0% |
| Q2 2020 | $697,000 | +45.2% | 100,900 | 0.0% | 0.01% | +25.0% |
| Q1 2020 | $480,000 | -45.3% | 100,900 | 0.0% | 0.01% | -11.1% |
| Q4 2019 | $878,000 | +157.5% | 100,900 | -1.5% | 0.01% | +125.0% |
| Q3 2019 | $341,000 | -32.7% | 102,400 | 0.0% | 0.00% | -20.0% |
| Q2 2019 | $507,000 | -22.0% | 102,400 | -2.2% | 0.01% | -28.6% |
| Q1 2019 | $650,000 | +12900.0% | 104,700 | +7378.6% | 0.01% | – |
| Q4 2018 | $5,000 | – | 1,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BML Capital Management, LLC | 1,087,961 | $2,012,728 | 1.74% |
| Opaleye Management Inc. | 2,880,000 | $5,328,000 | 1.60% |
| TANG CAPITAL MANAGEMENT LLC | 5,300,087 | $9,805,161 | 1.46% |
| Ardent Capital Management, Inc. | 923,463 | $1,708,407 | 1.23% |
| Beryl Capital Management LLC | 610,831 | $1,130,037 | 0.89% |
| Arena Investors LP | 610,639 | $1,129,682 | 0.88% |
| Omega Fund Management, LLC | 275,513 | $509,699 | 0.33% |
| Deep Track Capital, LP | 4,259,653 | $7,880,358 | 0.32% |
| PenderFund Capital Management Ltd. | 246,310 | $616 | 0.19% |
| GABELLI & Co INVESTMENT ADVISERS, INC. | 425,100 | $786,435 | 0.15% |